BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19233211)

  • 1. From structure to dynamics: frequency tuning in the p53-Mdm2 network I. Logical approach.
    Abou-Jaoudé W; Ouattara DA; Kaufman M
    J Theor Biol; 2009 Jun; 258(4):561-77. PubMed ID: 19233211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From structure to dynamics: frequency tuning in the p53-Mdm2 network. II Differential and stochastic approaches.
    Ouattara DA; Abou-Jaoudé W; Kaufman M
    J Theor Biol; 2010 Jun; 264(4):1177-89. PubMed ID: 20346959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a minimal model for p53 oscillations.
    Bottani S; Grammaticos B
    J Theor Biol; 2007 Nov; 249(2):235-45. PubMed ID: 17850824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining oscillations and variability in the p53-Mdm2 system.
    Proctor CJ; Gray DA
    BMC Syst Biol; 2008 Aug; 2():75. PubMed ID: 18706112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enhancement of stability of p53 in MTBP induced p53-MDM2 regulatory network.
    Alam MJ; Fatima N; Devi GR; Ravins ; Singh RK
    Biosystems; 2012 Nov; 110(2):74-83. PubMed ID: 23059707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oscillatory Dynamics of p53-Mdm2 Circuit in Response to DNA Damage Caused by Ionizing Radiation.
    Zhang Y; Liu H; Li Z; Miao Z; Zhou J
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1703-1713. PubMed ID: 30762566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.
    Hu W; Feng Z; Ma L; Wagner J; Rice JJ; Stolovitzky G; Levine AJ
    Cancer Res; 2007 Mar; 67(6):2757-65. PubMed ID: 17363597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities.
    Yang HY; Wen YY; Lin YI; Pham L; Su CH; Yang H; Chen J; Lee MH
    Oncogene; 2007 Nov; 26(52):7355-62. PubMed ID: 17546054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modelling of p53 basal dynamics and DNA damage response.
    Chong KH; Samarasinghe S; Kulasiri D
    Math Biosci; 2015 Jan; 259():27-42. PubMed ID: 25433195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady states and oscillations in the p53/Mdm2 network.
    Ciliberto A; Novak B; Tyson JJ
    Cell Cycle; 2005 Mar; 4(3):488-93. PubMed ID: 15725723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.
    Stommel JM; Wahl GM
    EMBO J; 2004 Apr; 23(7):1547-56. PubMed ID: 15029243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Abl as a modulator of p53.
    Levav-Cohen Y; Goldberg Z; Zuckerman V; Grossman T; Haupt S; Haupt Y
    Biochem Biophys Res Commun; 2005 Jun; 331(3):737-49. PubMed ID: 15865930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
    Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
    Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
    Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
    J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2001 Mar; 20(11):1267-75. PubMed ID: 11313871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
    Magrini R; Russo D; Fronza G; Inga A; Menichini P
    J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Behavior of p53 Driven by Delay and a Microrna-34a-Mediated Feedback Loop.
    Gao C; Liu H; Yan F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mediates the negative regulation of MDM2 by orphan receptor TR3.
    Zhao BX; Chen HZ; Lei NZ; Li GD; Zhao WX; Zhan YY; Liu B; Lin SC; Wu Q
    EMBO J; 2006 Dec; 25(24):5703-15. PubMed ID: 17139261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
    Giono LE; Manfredi JJ
    Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.